Enterprise Value
-23.35M
Cash
103.1M
Avg Qtr Burn
-11.31M
Short % of Float
0.64%
Insider Ownership
16.65%
Institutional Own.
68.01%
Qtr Updated
03/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|